What about HIV ? BLA will be fine it will be taken care of, it’s not like it doesn’t work anymore. It’s very clear to me it will be done at some point.

So we get approved to sell Leronlimab for HIV! What’s the SP for that ? 15-30? We are talking about a buyout at that price and we are right around the corner for approval for HIV? What am I missing?

Buyout gets us to 30 dollars a year sooner let’s say. I know people have been waiting a long time but if I remember correctly we have HIV to treat and possibly cure with a bone marrow transplant patient. Why else would all of those Doctors help cytodyn...... Because it’s an amazing drug !

So anyone who’s selling before 30 that’s fine it makes sense for some longs who’ve been here since .30- 1.50 and I get it.... However, I’m not selling anything under 30-50 maybe not even then.

Let’s be honest, NP can mess covid up ect not get good results with cancer and NASH trials stop enrolling because idk something went wrong.....

Leronlimab is going to still be sold/approved to treat HIV. If that somehow doesn’t workout then maybe I’d be worried we would see .30 or a company failing. I’m more worried I’ll wake up and see 30 and not have a sell order in. Although I’ll be probably fine with that because I’m thinking I’ll wake up one morning and see it trading for over 100 SP.

Yes cancer update would be great ! As far as I’m concerned sounds like an enrollment problem that can be fixed with money or better exposer of the company. Phase 2 for cancer I can see being done without a 1-2 years and phase 3 maybe another 1-2 years depending on how everything plays out in the long run. Maybe was less time.

Cancer is so far away at this point imo as we speak today. I wasn’t here for that. I was here for covid then I saw HIV and cancer. Now my head hurts trying to think of the 100 other things Leronlimab can treat.

I personally can’t wait to see us cure HIV using Leronlimab... Think about that ?!